Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1110

1.

Cell-lineage specificity of primary cilia during postnatal epididymal development.

Bernet A, Bastien A, Soulet D, Jerczynski O, Roy C, Bianchi Rodrigues Alves M, Lecours C, Tremblay MÈ, Bailey JL, Robert C, Belleannée C.

Hum Reprod. 2018 Sep 18. doi: 10.1093/humrep/dey276. [Epub ahead of print]

PMID:
30239723
2.

New Era in the Management of Melanoma Brain Metastases.

Tawbi HA, Boutros C, Kok D, Robert C, McArthur G.

Am Soc Clin Oncol Educ Book. 2018 May 23;(38):741-750. doi: 10.1200/EDBK_200819.

3.

Anatomy of the vestibulum esophagi and surgical implications during prosthetic laryngoplasty in horses.

Brandenberger O, Martens A, Robert C, Wiemer P, Pamela H, Vlaminck L, Barankova K, Haspeslagh M, Perkins JD, Ducharme N, Rossignol F.

Vet Surg. 2018 Sep 19. doi: 10.1111/vsu.12944. [Epub ahead of print]

PMID:
30230559
4.

« Le Lambeau », une expérience de lecture.

Robert CF.

Rev Med Suisse. 2018 Sep 12;14(618):1632. French. No abstract available.

PMID:
30226665
5.

Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial.

Dummer R, Ascierto PA, Gogas HJ, Arance A, Mandala M, Liszkay G, Garbe C, Schadendorf D, Krajsova I, Gutzmer R, Chiarion Sileni V, Dutriaux C, de Groot JWB, Yamazaki N, Loquai C, Moutouh-de Parseval LA, Pickard MD, Sandor V, Robert C, Flaherty KT.

Lancet Oncol. 2018 Sep 12. pii: S1470-2045(18)30497-2. doi: 10.1016/S1470-2045(18)30497-2. [Epub ahead of print]

PMID:
30219628
6.

Salt in stools is associated with obesity, gut halophilic microbiota and Akkermansia muciniphila depletion in humans.

Seck EH, Senghor B, Merhej V, Bachar D, Cadoret F, Robert C, Azhar EI, Yasir M, Bibi F, Jiman-Fatani AA, Konate DS, Musso D, Doumbo O, Sokhna C, Levasseur A, Lagier JC, Khelaifia S, Million M, Raoult D.

Int J Obes (Lond). 2018 Sep 11. doi: 10.1038/s41366-018-0201-3. [Epub ahead of print]

PMID:
30206336
7.

Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006.

Hamid O, Robert C, Ribas A, Hodi FS, Walpole E, Daud A, Arance AS, Brown E, Hoeller C, Mortier L, Schachter J, Long J, Ebbinghaus S, Ibrahim N, Butler M.

Br J Cancer. 2018 Sep 11. doi: 10.1038/s41416-018-0207-6. [Epub ahead of print]

PMID:
30202085
8.

Fungal resistance mediated by maize wall-associated kinase ZmWAK-RLK1 correlates with reduced benzoxazinoid content.

Yang P, Praz C, Li B, Singla J, Robert CAM, Kessel B, Scheuermann D, Lüthi L, Ouzunova M, Erb M, Krattinger SG, Keller B.

New Phytol. 2018 Sep 4. doi: 10.1111/nph.15419. [Epub ahead of print]

PMID:
30178602
9.

Accelerating MCMC algorithms.

Robert CP, Elvira V, Tawn N, Wu C.

Wiley Interdiscip Rev Comput Stat. 2018 Sep-Oct;10(5):e1435. doi: 10.1002/wics.1435. Epub 2018 Jun 13. Review.

10.

Human pegivirus (HPgV) isolates characterized by deep sequencing from HCV- and HIV-RNA positive blood donations, France.

Jordier F, Deligny ML, Barré R, Robert C, Galicher V, Uch R, Fournier PE, Raoult D, Biagini P.

J Med Virol. 2018 Aug 22. doi: 10.1002/jmv.25290. [Epub ahead of print]

PMID:
30133782
11.

Enterocolitis due to immune checkpoint inhibitors: a systematic review.

Soularue E, Lepage P, Colombel JF, Coutzac C, Faleck D, Marthey L, Collins M, Chaput N, Robert C, Carbonnel F.

Gut. 2018 Aug 21. pii: gutjnl-2018-316948. doi: 10.1136/gutjnl-2018-316948. [Epub ahead of print] Review.

PMID:
30131322
12.

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.

Sun R, Limkin EJ, Vakalopoulou M, Dercle L, Champiat S, Han SR, Verlingue L, Brandao D, Lancia A, Ammari S, Hollebecque A, Scoazec JY, Marabelle A, Massard C, Soria JC, Robert C, Paragios N, Deutsch E, Ferté C.

Lancet Oncol. 2018 Sep;19(9):1180-1191. doi: 10.1016/S1470-2045(18)30413-3. Epub 2018 Aug 14.

PMID:
30120041
13.

Plant iron acquisition strategy exploited by an insect herbivore.

Hu L, Mateo P, Ye M, Zhang X, Berset JD, Handrick V, Radisch D, Grabe V, Köllner TG, Gershenzon J, Robert CAM, Erb M.

Science. 2018 Aug 17;361(6403):694-697. doi: 10.1126/science.aat4082. Epub 2018 Aug 16.

PMID:
30115808
14.

Reply to: "Mortality due to immunotherapy related hepatitis".

De Martin E, Michot JM, Papouin B, Champiat S, Lambotte O, Robert C, Marabelle A, Guettier C, Samuel D.

J Hepatol. 2018 Oct;69(4):978-979. doi: 10.1016/j.jhep.2018.07.009. Epub 2018 Aug 7. No abstract available.

PMID:
30097327
15.

Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial.

Carlino MS, Long GV, Schadendorf D, Robert C, Ribas A, Richtig E, Nyakas M, Caglevic C, Tarhini A, Blank C, Hoeller C, Bar-Sela G, Barrow C, Wolter P, Zhou H, Emancipator K, Jensen EH, Ebbinghaus S, Ibrahim N, Daud A.

Eur J Cancer. 2018 Sep;101:236-243. doi: 10.1016/j.ejca.2018.06.034. Epub 2018 Aug 7.

16.

Association of homogeneous inflamed gene signature with a better outcome in patients with metastatic melanoma treated with MAGE-A3 immunotherapeutic.

Baurain JF, Robert C, Mortier L, Neyns B, Grange F, Lebbe C, Ulloa-Montoya F, De Sousa Alves PM, Gillet M, Louahed J, Jarnjak S, Lehmann FF.

ESMO Open. 2018 Jul 25;3(5):e000384. doi: 10.1136/esmoopen-2018-000384. eCollection 2018.

17.

Adjuvant Pembrolizumab in Resected Stage III Melanoma.

Eggermont AMM, Robert C, Suciu S.

N Engl J Med. 2018 Aug 9;379(6):593-595. doi: 10.1056/NEJMc1807505. No abstract available.

18.

Does tumour effraction during robotic partial nephrectomy have any impact on recurrence?

Khene ZE, Peyronnet B, Pradère B, Robert C, Goujon A, Kammerer-Jacquet SF, Verhoest G, Rioux-Leclercq N, Mathieu R, Bensalah K.

Int J Clin Oncol. 2018 Aug 6. doi: 10.1007/s10147-018-1331-2. [Epub ahead of print]

PMID:
30083964
19.

Radiomics in Nuclear Medicine Applied to Radiation Therapy: Methods, Pitfalls, and Challenges.

Reuzé S, Schernberg A, Orlhac F, Sun R, Chargari C, Dercle L, Deutsch E, Buvat I, Robert C.

Int J Radiat Oncol Biol Phys. 2018 May 22. pii: S0360-3016(18)30815-0. doi: 10.1016/j.ijrobp.2018.05.022. [Epub ahead of print]

PMID:
30064704
20.

Older melanoma patients aged 75 and above retain responsiveness to anti-PD1 therapy: results of a retrospective single-institution cohort study.

Ibrahim T, Mateus C, Baz M, Robert C.

Cancer Immunol Immunother. 2018 Jul 28. doi: 10.1007/s00262-018-2219-8. [Epub ahead of print]

PMID:
30056599
21.

Influence of drought on plant performance through changes in belowground tritrophic interactions.

Guyer A, Hibbard BE, Holzkämper A, Erb M, Robert CAM.

Ecol Evol. 2018 Jun 25;8(13):6756-6765. doi: 10.1002/ece3.4183. eCollection 2018 Jul.

22.

Root exudate metabolites drive plant-soil feedbacks on growth and defense by shaping the rhizosphere microbiota.

Hu L, Robert CAM, Cadot S, Zhang X, Ye M, Li B, Manzo D, Chervet N, Steinger T, van der Heijden MGA, Schlaeppi K, Erb M.

Nat Commun. 2018 Jul 16;9(1):2738. doi: 10.1038/s41467-018-05122-7.

23.

Do immune checkpoint inhibitors perform identically in patients with weight extremes?

Rassy EE, Ghosn M, Rassy NA, Assi T, Robert C.

Immunotherapy. 2018 Jul;10(9):733-736. doi: 10.2217/imt-2018-0053.

PMID:
30008261
24.

Estimating causal effects of time-dependent exposures on a binary endpoint in a high-dimensional setting.

Asvatourian V, Coutzac C, Chaput N, Robert C, Michiels S, Lanoy E.

BMC Med Res Methodol. 2018 Jul 3;18(1):67. doi: 10.1186/s12874-018-0527-5.

25.

LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity.

Nioche C, Orlhac F, Boughdad S, Reuzé S, Goya-Outi J, Robert C, Pellot-Barakat C, Soussan M, Frouin F, Buvat I.

Cancer Res. 2018 Aug 15;78(16):4786-4789. doi: 10.1158/0008-5472.CAN-18-0125. Epub 2018 Jun 29.

PMID:
29959149
26.

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Haanen JBAG, Carbonnel F, Robert C, Kerr KM, Peters S, Larkin J, Jordan K; ESMO Guidelines Committee.

Ann Oncol. 2018 Jun 15. doi: 10.1093/annonc/mdy162. [Epub ahead of print] No abstract available.

PMID:
29917046
27.

Whole-genome-based revisit of Photorhabdus phylogeny: proposal for the elevation of most Photorhabdus subspecies to the species level and description of one novel species Photorhabdus bodei sp. nov., and one novel subspecies Photorhabdus laumondii subsp. clarkei subsp. nov.

Machado RAR, Wüthrich D, Kuhnert P, Arce CCM, Thönen L, Ruiz C, Zhang X, Robert CAM, Karimi J, Kamali S, Ma J, Bruggmann R, Erb M.

Int J Syst Evol Microbiol. 2018 Aug;68(8):2664-2681. doi: 10.1099/ijsem.0.002820. Epub 2018 Jun 7.

PMID:
29877789
28.

Intragenic sequences in the trophectoderm harbour the greatest proportion of methylation errors in day 17 bovine conceptuses generated using assisted reproductive technologies.

O'Doherty AM, McGettigan P, Irwin RE, Magee DA, Gagne D, Fournier E, Al-Naib A, Sirard MA, Walsh CP, Robert C, Fair T.

BMC Genomics. 2018 Jun 5;19(1):438. doi: 10.1186/s12864-018-4818-3.

29.

Genome-wide DNA methylation patterns of bovine blastocysts derived from in vivo embryos subjected to in vitro culture before, during or after embryonic genome activation.

Salilew-Wondim D, Saeed-Zidane M, Hoelker M, Gebremedhn S, Poirier M, Pandey HO, Tholen E, Neuhoff C, Held E, Besenfelder U, Havlicek V, Rings F, Fournier E, Gagné D, Sirard MA, Robert C, Gad A, Schellander K, Tesfaye D.

BMC Genomics. 2018 Jun 1;19(1):424. doi: 10.1186/s12864-018-4826-3.

30.

Draft Genome and Description of Eisenbergiella massiliensis Strain AT11T: A New Species Isolated from Human Feces After Bariatric Surgery.

Togo AH, Diop A, Million M, Maraninchi M, Lagier JC, Robert C, Di Pinto F, Raoult D, Fournier PE, Bittar F.

Curr Microbiol. 2018 Oct;75(10):1274-1281. doi: 10.1007/s00284-018-1520-2. Epub 2018 Jun 1.

PMID:
29858619
31.

Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1.

Michot JM, Fusellier M, Champiat S, Velter C, Baldini C, Voisin AL, Danlos FX, Dakdouki YE, Annereau M, Mariette X, Robert C, Cherif K, Marabelle A, Mateus C, Lambotte O.

Ann Rheum Dis. 2018 Jun 1. pii: annrheumdis-2018-213677. doi: 10.1136/annrheumdis-2018-213677. [Epub ahead of print] No abstract available.

PMID:
29858173
32.

The new era of adjuvant therapies for melanoma.

Eggermont AMM, Robert C, Ribas A.

Nat Rev Clin Oncol. 2018 Sep;15(9):535-536. doi: 10.1038/s41571-018-0048-5. No abstract available.

33.

Effective Immunotherapy in Bone Marrow Metastatic Melanoma Presenting with Disseminated Intravascular Coagulopathy.

Gbadamosi B, Ezekwudo D, Nayak B, Yu Z, Gjorgova-Gjeorgjievski S, Xie M, Robert C, Jaiyesimi I, Huben M.

Case Reports Immunol. 2018 Feb 12;2018:4520294. doi: 10.1155/2018/4520294. eCollection 2018.

34.

Educator Sexual Misconduct and Texas Educator Discipline Database Construction.

Robert CE, Thompson DP.

J Child Sex Abus. 2018 May 24:1-19. doi: 10.1080/10538712.2018.1476999. [Epub ahead of print]

PMID:
29792583
35.

[New calculation algorithms in brachytherapy for iridium 192 treatments].

Robert C, Dumas I, Martinetti F, Chargari C, Haie-Meder C, Lefkopoulos D.

Cancer Radiother. 2018 Jun;22(4):319-325. doi: 10.1016/j.canrad.2017.11.007. Epub 2018 May 18. Review. French.

PMID:
29784552
36.

On the optimization of low-cost FDM 3D printers for accurate replication of patient-specific abdominal aortic aneurysm geometry.

Chung M, Radacsi N, Robert C, McCarthy ED, Callanan A, Conlisk N, Hoskins PR, Koutsos V.

3D Print Med. 2018;4(1):2. doi: 10.1186/s41205-017-0023-2. Epub 2018 Jan 17.

37.

Reply to: "Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?"

De Martin E, Michot JM, Champiat S, Lambotte O, Robert C, Marabelle A, Guettier C, Samuel D.

J Hepatol. 2018 Aug;69(2):550-551. doi: 10.1016/j.jhep.2018.04.019. No abstract available.

PMID:
29776713
38.

Feed supplementation with arginine and zinc on antioxidant status and inflammatory response in challenged weanling piglets.

Bergeron N, Robert C, Guay F.

Anim Nutr. 2017 Sep;3(3):236-246. doi: 10.1016/j.aninu.2017.06.009. Epub 2017 Jul 13.

39.

Predicting morbidity after robotic partial nephrectomy: The effect of tumor, environment, and patient-related factors.

Khene ZE, Peyronnet B, Kocher NJ, Robyak H, Robert C, Pradere B, Oger E, Kammerer-Jacquet SF, Verhoest G, Rioux-Leclercq N, Mathieu R, Raman JD, Bensalah K.

Urol Oncol. 2018 Jul;36(7):338.e19-338.e26. doi: 10.1016/j.urolonc.2018.04.005.

PMID:
29759510
40.

The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study.

Ascierto PA, Bastholt L, Ferrucci PF, Hansson J, Márquez Rodas I, Payne M, Robert C, Thomas L, Utikal JS, Wolter P, Kudlac A, Tuson H, McKendrick J.

Melanoma Res. 2018 Aug;28(4):333-340. doi: 10.1097/CMR.0000000000000455.

41.

Characterization of a novel Gram-stain-positive anaerobic coccus isolated from the female genital tract: Genome sequence and description of Murdochiella vaginalis sp. nov.

Diop K, Diop A, Khelaifia S, Robert C, Pinto FD, Delerce J, Raoult D, Fournier PE, Bretelle F, Fenollar F.

Microbiologyopen. 2018 Jun;7(3):e00570. doi: 10.1002/mbo3.570. Epub 2018 May 9.

42.

Longitudinal subungual acanthoma: one denomination for various clinical presentations.

Baran R, Moulonguet I, Goettmann-Bonvallot S, Encaoua R, Robert C.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1608-1613. doi: 10.1111/jdv.15017. Epub 2018 Jun 7.

PMID:
29705997
43.

Imputation-based analysis of MICA alleles in the susceptibility to ankylosing spondylitis.

Cortes A, Gladman D, Raychaudhuri S, Cui J, Wheeler L, Brown MA; International Genetics of Ankylosing Spondylitis Consortium (IGAS).

Ann Rheum Dis. 2018 Apr 28. pii: annrheumdis-2018-213413. doi: 10.1136/annrheumdis-2018-213413. [Epub ahead of print] No abstract available.

PMID:
29705741
44.

'Cellulomonas timonensis' sp. nov., taxonogenomics description of a new bacterial species isolated from human gut.

Ndongo S, Bittar F, Beye M, Robert C, Di Pinto F, Fournier PE, Raoult D, Lagier JC.

New Microbes New Infect. 2018 Feb 8;23:7-16. doi: 10.1016/j.nmni.2018.01.003. eCollection 2018 May.

45.

Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab.

Joseph RW, Elassaiss-Schaap J, Kefford R, Hwu WJ, Wolchok JD, Joshua AM, Ribas A, Hodi FS, Hamid O, Robert C, Daud A, Dronca R, Hersey P, Weber JS, Patnaik A, de Alwis DP, Perrone A, Zhang J, Kang SP, Ebbinghaus S, Anderson KM, Gangadhar TC.

Clin Cancer Res. 2018 Apr 23. doi: 10.1158/1078-0432.CCR-17-2386. [Epub ahead of print]

PMID:
29685882
46.

Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.

Verver D, van Klaveren D, van Akkooi ACJ, Rutkowski P, Powell BWEM, Robert C, Testori A, van Leeuwen BL, van der Veldt AAM, Keilholz U, Eggermont AMM, Verhoef C, Grünhagen DJ.

Eur J Cancer. 2018 Jun;96:25-33. doi: 10.1016/j.ejca.2018.02.022. Epub 2018 Apr 13.

PMID:
29660597
47.

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.

Eggermont AMM, Blank CU, Mandala M, Long GV, Atkinson V, Dalle S, Haydon A, Lichinitser M, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Maio M, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan P, Ibrahim N, Marreaud S, van Akkooi ACJ, Suciu S, Robert C.

N Engl J Med. 2018 May 10;378(19):1789-1801. doi: 10.1056/NEJMoa1802357. Epub 2018 Apr 15.

PMID:
29658430
48.

Sentinel lymph node biopsy in 33 non-melanoma skin cancers of the head and neck: A twelve-year experience with long-term follow-up.

Foy JP, Kolb F, Routier E, Cavalcanti A, Lumbroso J, Tomasic G, Mateus C, Temam S, Robert C, Moya-Plana A.

Clin Otolaryngol. 2018 Mar 24. doi: 10.1111/coa.13100. [Epub ahead of print] No abstract available.

PMID:
29575799
49.

Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial.

Dummer R, Ascierto PA, Gogas HJ, Arance A, Mandala M, Liszkay G, Garbe C, Schadendorf D, Krajsova I, Gutzmer R, Chiarion-Sileni V, Dutriaux C, de Groot JWB, Yamazaki N, Loquai C, Moutouh-de Parseval LA, Pickard MD, Sandor V, Robert C, Flaherty KT.

Lancet Oncol. 2018 May;19(5):603-615. doi: 10.1016/S1470-2045(18)30142-6. Epub 2018 Mar 21.

PMID:
29573941
50.

A Participatory System for Preventing Pandemics of Animal Origins: Pilot Study of the Participatory One Health Disease Detection (PODD) System.

Yano T, Phornwisetsirikun S, Susumpow P, Visrutaratna S, Chanachai K, Phetra P, Chaisowwong W, Trakarnsirinont P, Hemwan P, Kaewpinta B, Singhapreecha C, Kreausukon K, Charoenpanyanet A, Robert CS, Robert L, Rodtian P, Mahasing S, Laiya E, Pattamakaew S, Tankitiyanon T, Sansamur C, Srikitjakarn L.

JMIR Public Health Surveill. 2018 Mar 21;4(1):e25. doi: 10.2196/publichealth.7375.

Supplemental Content

Loading ...
Support Center